|
Reproductive Health
|
N01.400.625 |
|
|
Cuminum
|
B01.650.940.800.575.912.250.075.233 |
|
|
National Human Genome Research Institute (U.S.)
|
N03.540.052.750.325 |
|
|
Sarcosine
|
D12.125.481.700.374 |
|
|
Ovarian Neoplasms
|
C04.588.322.455 |
|
|
Contraceptive Agents
|
D27.505.954.705.360 |
|
|
Cyclin-Dependent Kinase Inhibitor p21
|
D12.776.157.687.250 |
|
|
Pseudomonas syringae
|
B03.440.400.425.625.625.770 |
|
|
Factor V Deficiency
|
C15.378.100.141.300 |
|
|
COVID-19
|
C01.925.782.600.550.200.163 |
|
|
Clay
|
D20.721.250 |
|
|
Viral Load
|
G06.920.850 |
|
|
Stimuli Responsive Polymers
|
J01.637.051.860.500 |
|
|
PC12 Cells
|
A11.251.210.190.750 |
|
|
S-Adenosylmethionine
|
D03.633.100.759.590.138.264 |
|
|
ATP Binding Cassette Transporter 1
|
D064286 |
[A superfamily of integral ATP-binding cassette membrane proteins whose expression pattern is consistent with a role in lipid (cholesterol) efflux. It is implicated in TANGIER DISEASE, characterized by accumulation of cholesteryl ester in various tissues.
] |
|
Thuja
|
B01.650.940.800.575.912.625.750.799 |
|
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
D27.505.519.186.071.202.370 |
|
|
Anticholesteremic Agents
|
D27.505.519.186.071.202 |
|
|
Factor VII Deficiency
|
C15.378.100.141.310 |
|
